Concepedia

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Peter G. Pappas, C. M. F. Rotstein, Robert F. Betts, Márcio Nucci, Deepak Talwar, Jan J. De Waele, José A. Vázquez, B Dupont, David L. Horn, Luis Ostrosky‐Zeichner,

Clinical Infectious Diseases · 2007 · 628 citations · 23 references

DOIFull text

Open access

Abstract

Dosages of micafungin 100 mg daily and 150 mg daily were noninferior to a standard dosage of caspofungin for the treatment of candidemia and other forms of invasive candidiasis.

References

23

A sharper Bonferroni procedure for multiple tests of significance

Yosef Hochberg · Biometrika · 1988 · 4.7K citations

, , +14

Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study

Hilmar Wisplinghoff, Thomas Bischoff, Sandra Tallent et al. · Clinical Infectious Diseases · 2004 · 4.5K citations · Full text

Guidelines for Treatment of Candidiasis

Peter G. Pappas, John Rex, Jack D. Sobel et al. · Clinical Infectious Diseases · 2004 · 1.4K citations · Full text

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

Jorge Mora-Duarte, Robert F. Betts, Coleman Rotstein et al. · New England Journal of Medicine · 2002 · 1.4K citations · Full text

Attributable Mortality of Nosocomial Candidemia, Revisited

Stephen H. Gillespie, Kyungwon Lee, Jeffery Vande Berg et al. · Clinical Infectious Diseases · 2003 · 1.1K citations